Purchase Order HT001416P1030
Award Date 5/1/16
Potential Completion Date 4/30/21
Potential Value $105K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Belvoir, VA 22060, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $151,200.00. The contract is for the provision of ThyroSeq V.2 molecular testing services, which are used for cancer screening and diagnosis. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on delivering ThyroSeq testing to federal agencies, including the Department...
- The Defense Health Agency awarded a $105,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on March 22, 2021, for ThyroSeq molecular diagnostic testing services. The contract, which is scheduled for completion by April 30, 2025, will be performed at Fort Belvoir, Virginia. No set-aside designation was used for this award. Cytopath Biopsy Lab Inc. specializes in anatomic pathology and molecular diagnostic laboratory services, with a primary focus on...
- This is a firm fixed price purchase order for $77,440.80 awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Cytopath Biopsy Lab Inc. (doing business as Cblpath) to provide laboratory testing services related to the ThyroSeq V.2 molecular diagnostic test. The award supports the agency's cancer screening and diagnosis programs, particularly for veterans and active military members. Cytopath Biopsy Lab Inc. has provided similar ThyroSeq testing services to...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq testing kits. The $320,000.00 contract is to deliver specialized thyroid cancer diagnostic testing services, including ThyroSeq analysis of genetic mutations to evaluate malignancy of thyroid nodules, to support screening programs at VA medical centers and associated healthcare networks...
- This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq laboratory tests to determine thyroid nodule malignancy for surgical decision making. The $72,000.00 award is part of an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle between the VA and Cytopath Biopsy Lab Inc. to support cancer screening and diagnosis programs within the VA healthcare network. The contract...
- This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of ThyroSeq genomic classifier tests, which are specialized molecular diagnostic tests used to evaluate thyroid cancer risk. The contract has a ceiling value of $104,000.00 and a period of performance through October 31, 2024....
- This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract provides for molecular thyroid reference testing services, specifically ThyroSeq genetic mutation analysis, to support the VA's cancer screening and diagnosis programs. The $138,000.00 task order funds the third year of services under this open-ended BPA, which was originally awarded without a set-aside....
- This is a firm fixed price purchase order awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of THROSEQ V.2 MOLECULAR TESTING services. The contract has a completion date of September 30, 2017 and a potential value of $150,000.00. Cblpath is a for-profit organization that provides specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis utilizing next-generation...
- This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for...